New pain relief option studied for mohs skin cancer surgery

NCT ID NCT07200544

First seen Oct 31, 2025 · Last updated May 15, 2026 · Updated 26 times

Summary

This study looks at whether a single dose of meloxicam (a pain reliever) can control pain better than the usual ibuprofen after Mohs surgery for skin cancer. About 300 adults will be split into three groups: one gets a low dose of meloxicam, one gets a higher dose, and one gets standard care with ibuprofen and acetaminophen. Everyone will also take acetaminophen as needed. Participants will report their pain levels and satisfaction through surveys.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SKIN CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Oklahoma Health Sciences Center

    RECRUITING

    Oklahoma City, Oklahoma, 73104, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.